UCSF Alumni

Narges Alipanah-Lechner, MD, MAS

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0002-8381-5701 Additional info
vCardDownload vCard

Collapse Biography 
Collapse Education and Training
Johns Hopkins UniversityB.A.06/2009Public Health
UCSFM.D.06/2015Medicine
Santa Clara Valley Medical CenterResidency06/2018Internal Medicine
Santa Clara Valley Medical CenterChief Residency06/2019Internal Medicine
UCSFFellowship06/2022Pulmonary and Critical Care Medicine
Show more
Collapse Awards and Honors
American Society for Clinical Investigation2024Emerging Generation Award

Collapse Overview 
Collapse Overview
Dr. Narges Alipanah-Lechner is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at UCSF. She received her undergraduate degree from Johns Hopkins University and her medical degree and master's degree in clinical and epidemiological research from UCSF. Dr. Alipanah-Lechner's research interest is to apply complementary systems biology approaches within precision medicine to improve the diagnosis and treatment of patients with syndromes of critical illness such as sepsis and ARDS. She currently attends in the intensive care units and the pulmonary function laboratory at UCSF.

Collapse Research 
Collapse Research Activities and Funding
Proteomic and metabolomic trajectories of ARDS molecular phenotypes
NIH K23HL173659Dec 20, 2024 - Nov 30, 2029
Role: Principal Investigator
Biomarkers and subphenotypes predictive of clinical outcomes in patients with COVID-19 related acute respiratory distress syndrome
NIH F32HL165828Jan 1, 2023 - Jun 30, 2024
Role: Principal Investigator

Collapse Bibliographic 
Collapse Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU. Am J Respir Crit Care Med. 2024 07 15; 210(2):155-166. Gordon AC, Alipanah-Lechner N, Bos LD, Dianti J, Diaz JV, Finfer S, Fujii T, Giamarellos-Bourboulis EJ, Goligher EC, Gong MN, Karakike E, Liu VX, Lumlertgul N, Marshall JC, Menon DK, Meyer NJ, Munroe ES, Myatra SN, Ostermann M, Prescott HC, Randolph AG, Schenck EJ, Seymour CW, Shankar-Hari M, Singer M, Smit MR, Tanaka A, Taccone FS, Thompson BT, Torres LK, van der Poll T, Vincent JL, Calfee CS. PMID: 38687499; PMCID: PMC11273306.
    View in: PubMed   Mentions: 6     Fields:    Translation:Humans
  2. The Plasma Lipidomic Landscape in Patients with Sepsis due to Community-acquired Pneumonia. Am J Respir Crit Care Med. 2024 04 15; 209(8):973-986. Chouchane O, Schuurman AR, Reijnders TDY, Peters-Sengers H, Butler JM, Uhel F, Schultz MJ, Bonten MJ, Cremer OL, Calfee CS, Matthay MA, Langley RJ, Alipanah-Lechner N, Kingsmore SF, Rogers A, van Weeghel M, Vaz FM, van der Poll T. PMID: 38240721.
    View in: PubMed   Mentions: 5     Fields:    Translation:Humans
  3. Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial. Crit Care. 2024 02 21; 28(1):56. Alipanah-Lechner N, Hurst-Hopf J, Delucchi K, Swigart L, Willmore A, LaCombe B, Dewar R, Lane HC, Lallemand P, Liu KD, Esserman L, Matthay MA, Calfee CS, I-SPY COVID Consortium. PMID: 38383504; PMCID: PMC10882728.
    View in: PubMed   Mentions:    Fields:    Translation:HumansCells
  4. From Berlin to Global: The Need for Syndromic Definitions of Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024 01 01; 209(1):21-23. Alipanah-Lechner N, Cavalcanti AB, Diaz J, Ferguson ND, Myatra SN, Calfee CS. PMID: 37816094; PMCID: PMC10870889.
    View in: PubMed   Mentions: 1     Fields:    Translation:Humans
  5. Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDS. Am J Physiol Lung Cell Mol Physiol. 2023 03 01; 324(3):L297-L306. Alipanah-Lechner N, Neyton L, Mick E, Willmore A, Leligdowicz A, Contrepois K, Jauregui A, Zhuo H, Hendrickson C, Gomez A, Sinha P, Kangelaris KN, Liu KD, Matthay MA, Rogers AJ, Calfee CS. PMID: 36648136; PMCID: PMC9988532.
    View in: PubMed   Mentions: 8     Fields:    Translation:Humans
  6. Interventions to enhance treatment adherence and retention in care for HIV-TB. Int J Tuberc Lung Dis. 2022 03 01; 26(3):279-281. Hudson M, Alipanah N, Singh S, Nahid P. PMID: 35197169.
    View in: PubMed   Mentions:    Fields:    Translation:Humans
  7. Phenotyping in acute respiratory distress syndrome: state of the art and clinical implications. Curr Opin Crit Care. 2022 02 01; 28(1):1-8. Alipanah N, Calfee CS. PMID: 34670998; PMCID: PMC8782441.
    View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
  8. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19. EClinicalMedicine. 2020 Oct; 27:100518. Shah SJ, Barish PN, Prasad PA, Kistler A, Neff N, Kamm J, Li LM, Chiu CY, Babik JM, Fang MC, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Castaneda G, CZB CLIAhub Consortium, Dadasovich RM, Davis J, Deng X, DeRisi JL, Detweiler AM, Federman S, Haliburton J, Hao S, Kerkhoff AD, Kumar GR, Malcolm KB, Mann SA, Martinez S, Mary RK, Mick E, Mwakibete L, Najafi N, Peluso MJ, Phelps M, Pisco AO, Ratnasiri K, Rubio LA, Sellas A, Sherwood KD, Sheu J, Spottiswoode N, Tan M, Yu G, Kangelaris KN, Langelier C. PMID: 32864588; PMCID: PMC7447618.
    View in: PubMed   Mentions: 46  
  9. Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis. Ann Am Thorac Soc. 2020 08; 17(8):911-917. Berger CA, Alipanah N, Kheir F, Ruminjo JK, Nahid P, Thomson C. PMID: 32464069.
    View in: PubMed   Mentions: 2     Fields:    Translation:Humans
  10. Management and Outcomes of Critically-III Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series. medRxiv. 2020 May 29. Vanderburg S, Alipanah N, Crowder R, Yoon C, Wang R, Thakur N, Slown K, Shete PB, Rofael M, Metcalfe JZ, Merrifield C, Marquez C, Malcolm K, Lipnick M, Jain V, Gomez A, Burns G, Brown LB, Berger C, Auyeung V, Cattamanchi A, Hendrickson CM. PMID: 32511538; PMCID: PMC7273306.
    View in: PubMed   Mentions:
  11. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19. medRxiv. 2020 May 06. Shah SJ, Barish PN, Prasad PA, Kistler AL, Neff N, Kamm J, Li LM, Chiu CY, Babick JM, Fang MC, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Davis JM, Castenada GD, Consortium C, Dadasovich RM, Deng X, DeRisi JL, Detweiler AM, Federman S, Haliburton JR, Hao SL, Kerkhoff AD, Kumar R, Malcolm K, Mann SA, Martinez SP, Marya R, Mick E, Mwakibete LL, Najafi N, Peluso MJ, Phelps MS, Pisco AO, Ratnasiri K, Rubio LA, Sellas AB, Sherwood KD, Sheu J, Spottiswoode N, Tan M, Yu G, Kangelaris KN, Langelier C. PMID: 32511488; PMCID: PMC7273256.
    View in: PubMed   Mentions: 2  
  12. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics (Basel). 2019 May 30; 9(2). Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P. PMID: 31151255; PMCID: PMC6627302.
    View in: PubMed   Mentions: 2  
  13. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018 07; 15(7):e1002595. Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P. PMID: 29969463; PMCID: PMC6029765.
    View in: PubMed   Mentions: 186     Fields:    Translation:Humans
  14. Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis. Int J Tuberc Lung Dis. 2016 11; 20(11):1522-1528. Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P. PMID: 27776595.
    View in: PubMed   Mentions: 7     Fields:    Translation:Humans
  15. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):853-67. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. PMID: 27621353; PMCID: PMC6366011.
    View in: PubMed   Mentions: 102     Fields:    Translation:HumansCellsPHPublic Health
  16. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):e147-e195. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. PMID: 27516382; PMCID: PMC6590850.
    View in: PubMed   Mentions: 448     Fields:    Translation:HumansCellsPHPublic Health
  17. Genitourinary exam skills training curriculum for medical students: a follow-up study of comfort and skill utilization. J Endourol. 2012 Oct; 26(10):1350-5. Kaplan AG, Abdelshehid CS, Alipanah N, Zamansani T, Lee J, Kolla SB, Sountoulides PG, Graversen J, Lusch A, Kaufmann OG, Louie M, Clayman RV, McDougall EM. PMID: 22712690.
    View in: PubMed   Mentions: 5     Fields:    Translation:Humans
  18. Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria. Am J Med Sci. 2009 Mar; 337(3):182-4. Tabarsi P, Baghaei P, Farnia P, Mansouri N, Chitsaz E, Sheikholeslam F, Marjani M, Rouhani N, Mirsaeidi M, Alipanah N, Amiri M, Masjedi MR, Mansouri D. PMID: 19301453.
    View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
  19. Low serum carotenoids are associated with a decline in walking speed in older women. J Nutr Health Aging. 2009 Mar; 13(3):170-5. Alipanah N, Varadhan R, Sun K, Ferrucci L, Fried LP, Semba RD. PMID: 19262947; PMCID: PMC2748676.
    View in: PubMed   Mentions: 32     Fields:    Translation:Humans
  20. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran. Respirology. 2008 Jan; 13(1):108-11. Tabarsi P, Nooraki A, Mirsaeidi M, Amiri M, Baghaei P, Farnia P, Kazempour M, Heidarnazhad H, Alipanah N, Mansouri D, Masjedi MR. PMID: 18197919.
    View in: PubMed   Mentions:    Fields:    Translation:Humans
  21. Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran. Saudi Med J. 2008 Jan; 29(1):148-50. Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, Alipanah N, Emami H, Novin A, Mansouri D, Masjedi MR, Velayati AA. PMID: 18176695.
    View in: PubMed   Mentions: 2     Fields:    Translation:Humans
Narges's Networks
Concepts (99)
Derived automatically from this person's publications.
_
Co-Authors (44)
People in Profiles who have published with this person.
_
Similar People (60)
People who share similar concepts with this person.
_
Same Department
Search Department
_